Abstract 782: The genetic and epigenetic abnormalities of plasma cfDNA as liquid biopsy biomarkers to diagnose hepatocellular carcinoma
Yuying Wang, Jia Fan(Nanjing Tech University), Guanghui Yang(BGI Group (China)), Xin‐Rong Yang(Sun Yat-sen University), Chichuan Liu(BGI Group (China)), Jie Yuan(National Clinical Research Center for Digestive Diseases), Yupeng Wang(Guangdong University of Technology), Jian Zhou(The First People's Hospital of Guiyang), Jianlong Sun(ShanghaiTech University), Ao Huang(Beijing University of Civil Engineering and Architecture), Jianchao Zheng(Nanjing Medical University), Ruijingfang Jiang, Zhilong Li(University Town of Shenzhen), Jiaxi Peng(Dalian Institute of Chemical Physics)
Cited by 2
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Clonal dynamics of native haematopoiesis
|Nature|2014|838
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
|Journal of Clinical Oncology|2011|644